The efficacy of gabapentin for the treatment of refractory cough associated with interstitial lung disease: study protocol for a randomized, double-blind and placebo-controlled clinical trial

Peer Review reports

Original Submission
31 Aug 2021	Submitted	Original manuscript
10 Nov 2021	Reviewed	Reviewer Report - Muslim Syed
10 Jan 2022	Reviewed	Reviewer Report - Fernando Zanela da Silva Arêas
24 Jan 2022	Author responded	Author comments - Ronglin Gao
Resubmission - Version 2
24 Jan 2022	Submitted	Manuscript version 2
Publishing
27 Jan 2022	Editorially accepted
21 Feb 2022	Article published	10.1186/s13063-022-06059-5

Back to article page